• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用冈珀茨函数将预期寿命的变化与标准化死亡率相关联。

The use of the Gompertz function to relate changes in life expectancy to the standardized mortality ratio.

作者信息

Haybittle J L

机构信息

MRC Cancer Trials Office, Cambridge, UK.

出版信息

Int J Epidemiol. 1998 Oct;27(5):885-9. doi: 10.1093/ije/27.5.885.

DOI:10.1093/ije/27.5.885
PMID:9839748
Abstract

BACKGROUND

Change in life expectancy may be more readily appreciated by a lay person as a measure of risk than the standardized mortality ratio (SMR).

METHODS

The linear increase in the logarithm of the age-specific mortality rates with age (the Gompertz function) is used to deduce formulae connecting SMR with change in life expectancy. Their validity is checked by a comparison between the 1992 and 1952 mortality data for England and Wales, and between smokers and non-smokers in the American Cancer Society's second Cancer Prevention Study.

RESULTS

It is shown that the Gompertz function is a good fit to mortality data for England and Wales from age 30 years upwards. Changes in life expectancy at ages 15, 25, 45 and 65 are presented for values of SMR from 0.5 to 3. A very simple formula connecting the two is valid at ages 15 and 25, and provides a reasonable approximation at age 45.

CONCLUSIONS

The Gompertz relationship can be used to calculate the change in life expectancy corresponding to a particular SMR over a greater range than have previous methods, and, although subject to some uncertainties, can provide a quick method of judging the change in life expectancy that is associated with a given SMR value.

摘要

背景

对于非专业人士而言,预期寿命的变化作为一种风险衡量指标,可能比标准化死亡率(SMR)更容易理解。

方法

利用特定年龄死亡率的对数随年龄的线性增长(冈珀茨函数)来推导将SMR与预期寿命变化联系起来的公式。通过比较1992年和1952年英格兰和威尔士的死亡率数据,以及美国癌症协会第二次癌症预防研究中吸烟者和非吸烟者的数据,来检验这些公式的有效性。

结果

结果表明,冈珀茨函数非常适合30岁及以上英格兰和威尔士的死亡率数据。给出了SMR值从0.5到3时,15岁、25岁、45岁和65岁时预期寿命的变化情况。一个将两者联系起来的非常简单的公式在15岁和25岁时有效,在45岁时提供了合理的近似值。

结论

冈珀茨关系可用于计算与特定SMR相对应的预期寿命变化,其适用范围比以前的方法更广,并且尽管存在一些不确定性,但可以提供一种快速方法来判断与给定SMR值相关的预期寿命变化。

相似文献

1
The use of the Gompertz function to relate changes in life expectancy to the standardized mortality ratio.使用冈珀茨函数将预期寿命的变化与标准化死亡率相关联。
Int J Epidemiol. 1998 Oct;27(5):885-9. doi: 10.1093/ije/27.5.885.
2
Trends in life expectancy and age-specific mortality in England and Wales, 1970-2016, in comparison with a set of 22 high-income countries: an analysis of vital statistics data.1970-2016 年英格兰和威尔士与 22 个高收入国家相比的预期寿命和年龄别死亡率趋势:生命统计数据分析。
Lancet Public Health. 2019 Nov;4(11):e575-e582. doi: 10.1016/S2468-2667(19)30177-X.
3
Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.1990年香港燃料含硫量限制立法的影响。
Res Rep Health Eff Inst. 2012 Aug(170):5-91.
4
Loss of life expectancy derived from a standardized mortality ratio in Denmark, Finland, Norway and Sweden.丹麦、芬兰、挪威和瑞典的标准化死亡率导致的预期寿命损失。
Scand J Public Health. 2018 Nov;46(7):767-773. doi: 10.1177/1403494817749050. Epub 2018 Jan 31.
5
Standardized mortality ratio and life expectancy: a comparative study of Chinese mortality.
Int J Epidemiol. 2000 Oct;29(5):852-5. doi: 10.1093/ije/29.5.852.
6
The standardized mortality ratio and life expectancy.
Am J Epidemiol. 1992 Apr 1;135(7):824-31. doi: 10.1093/oxfordjournals.aje.a116369.
7
Statistical analysis of the standardized mortality ratio and life expectancy.标准化死亡率比和预期寿命的统计分析。
Am J Epidemiol. 1996 Apr 15;143(8):832-40. doi: 10.1093/oxfordjournals.aje.a008822.
8
The effect of revised populations on mortality statistics for the United States, 2000.2000年美国人口修订对死亡率统计数据的影响。
Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24.
9
Why has mortality in England and Wales been increasing? An iterative demographic analysis.英格兰和威尔士的死亡率为何一直在上升?一项迭代人口分析。
J R Soc Med. 2017 Apr;110(4):153-162. doi: 10.1177/0141076817693599. Epub 2017 Feb 16.
10
The global impact of noncommunicable diseases: estimates and projections.非传染性疾病的全球影响:评估与预测
World Health Stat Q. 1988;41(3-4):255-66.

引用本文的文献

1
The impact of non-pharmaceutical interventions on COVID-19 transmission and its effect on life expectancy in two European regions.非药物干预措施对两个欧洲地区新冠病毒传播的影响及其对预期寿命的作用。
BMC Public Health. 2025 Mar 14;25(1):1004. doi: 10.1186/s12889-025-22239-9.
2
Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and Race: A Cohort-Based Study of Medicare Beneficiaries.急性心肌梗死后按性别和种族划分的预期寿命及潜在寿命损失年数:一项基于队列的医疗保险受益人群研究。
J Am Coll Cardiol. 2015 Aug 11;66(6):645-55. doi: 10.1016/j.jacc.2015.06.022.
3
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
在心力衰竭人群中通过一级预防植入式心脏复律除颤器治疗实现生存获益最大化。
Circulation. 2009 Sep 8;120(10):835-42. doi: 10.1161/CIRCULATIONAHA.108.816884. Epub 2009 Aug 24.
4
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.增加1年寿命所需的治疗时间:一种用于估计随机试验治疗效果的新指标。
Eur J Heart Fail. 2009 Mar;11(3):256-63. doi: 10.1093/eurjhf/hfn048. Epub 2009 Jan 22.
5
Determining the lifetime density function using a continuous approach.使用连续方法确定寿命密度函数。
J Epidemiol Community Health. 2007 Oct;61(10):923-5. doi: 10.1136/jech.2006.052639.
6
Estimated life expectancy of Parkinson's patients compared with the UK population.帕金森病患者与英国人群相比的预期寿命估计。
J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1304-9. doi: 10.1136/jnnp.2006.100107. Epub 2007 Mar 30.
7
Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.开发一种经济模型以评估慢性阻塞性肺疾病治疗干预措施的成本效益。
Pharmacoeconomics. 2005;23(6):619-37. doi: 10.2165/00019053-200523060-00008.
8
Life expectancy as a summary of mortality in a population: statistical considerations and suitability for use by health authorities.预期寿命作为人群死亡率的一项汇总指标:统计考量及卫生当局的适用情况
J Epidemiol Community Health. 2001 Jan;55(1):38-43. doi: 10.1136/jech.55.1.38.